Open AccessFactors Associated With Off-Label Utilization of Second-Generation Antipsychotics Among Publicly Insured Adults
Author(s) -
Marcela HorvitzLen,
Rita Volya,
Simon Hollands,
Katya Zelevinsky,
Andrew W. Mulcahy,
Julie M. Donohue,
SharonLise T. Normand
Publication year - 2021
Publication title -
psychiatric services
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.517
H-Index - 145
eISSN - 1557-9700
pISSN - 1075-2730
DOI - 10.1176/appi.ps.202000381
Subject(s) - medicaid , medicine , odds ratio , odds , ethnic group , confidence interval , drug utilization review , medical prescription , off label use , antipsychotic , medical expenditure panel survey , environmental health , demography , gerontology , logistic regression , psychiatry , health insurance , schizophrenia (object oriented programming) , health care , pathology , sociology , anthropology , economics , pharmacology , economic growth
Off-label utilization of second-generation antipsychotic medications may expose patients to significant risks. The authors examined the prevalence, temporal trends, and factors associated with off-label utilization of second-generation antipsychotics among publicly insured adults.